Evidence map›Paper›PMID 39602515›Full record

ArticleScience robotics2024

Bioinspired designer DNA NanoGripper for virus sensing and potential inhibition.

Lifeng Zhou, Yanyu Xiong, Abhisek Dwivedy, Mengxi Zheng, Laura Cooper, Skye Shepherd, Tingjie Song, Wei Hong, Linh T P Le, Xin Chen and 5 more

Abstract read
In one paragraph

Article in Science robotics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. DNA Nanostructure-Templated Multivalency Enables Broad-Spectrum Virus Inhibition.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Article
  6. Article
  7. Unraveling the Folding Dynamics of DNA Origami Structures.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Lifeng ZhouCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0001-5479-3681
Yanyu XiongCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0002-4399-6253
Abhisek DwivedyCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0001-9745-8138
Mengxi ZhengCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0002-1625-6663
Laura CooperDepartment of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.ORCID 0000-0002-6322-1260
Skye ShepherdHolonyak Micro and Nanotechnology Lab, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0002-5684-7126
Tingjie SongCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Wei HongCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0001-7866-9917
Linh T P LeDepartment of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0009-0003-8053-5063
Xin ChenCenter for Biophysics and Quantitative Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0002-4695-6898
Saurabh UmraoCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Lijun RongDepartment of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.ORCID 0000-0003-3938-0445
Tong WangAdvanced Science Research Center at Graduate Center, City University of New York, New York, NY 10031, USA.ORCID 0000-0001-6615-000X
Brian T CunninghamCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0002-9681-2104
Xing WangCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.ORCID 0000-0001-9930-3287

Funding

Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva SampleR44DE030852 · NIDCR · ATOM BIOWORKS INC · PI YAO, XIAOHU · 2021 to 2022
$1.7M
Programming designer DNA nanostructures for blocking enveloped viral infectionR21AI166898 · NIAID · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI HUANG, WEISHAN, WANG, XING · 2023 to 2024
$431k
A Rapid and Sensitive Technology for Direct Sensing of Intact SARS-CoV-2 Virions Using Designer DNA Nanostructure Probes and a Smartphone FluorimeterR21EB031310 · NIBIB · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI CUNNINGHAM, BRIAN T., WANG, XING · 2021 to 2021
$422k
NIAID NIH HHS R21 AI166898NIBIB NIH HHS R21 EB031310NIDCR NIH HHS R44 DE030852
6 · The paper itself

Abstract

DNA has shown great biocompatibility, programmable mechanical properties, and precise structural addressability at the nanometer scale, rendering it a material for constructing versatile nanorobots for biomedical applications. Here, we present the design principle, synthesis, and characterization of a DNA nanorobotic hand, called DNA NanoGripper, that contains a palm and four bendable fingers as inspired by naturally evolved human hands, bird claws, and bacteriophages. Each NanoGripper finger consists of three phalanges connected by three rotatable joints that are bendable in response to the binding of other entities. NanoGripper functions are enabled and driven by the interactions between moieties attached to the fingers and their binding partners. We demonstrate that the NanoGripper can be engineered to effectively interact with and capture nanometer-scale objects, including gold nanoparticles, gold NanoUrchins, and SARS-CoV-2 virions. With multiple DNA aptamer nanoswitches programmed to generate a fluorescent signal that is enhanced on a photonic crystal platform, the NanoGripper functions as a highly sensitive biosensor that selectively detects intact SARS-CoV-2 virions in human saliva with a limit of detection of ~100 copies per milliliter, providing a sensitivity equal to that of reverse transcription quantitative polymerase chain reaction (RT-qPCR). Quantified by flow cytometry assays, we demonstrated that the NanoGripper-aptamer complex can effectively block viral entry into the host cells, suggesting its potential for inhibiting virus infections. The design, synthesis, and characterization of a sophisticated nanomachine that can be tailored for specific applications highlight a promising pathway toward feasible and efficient solutions to the detection and potential inhibition of virus infections.

Indexed as

Aptamers, NucleotideBiosensing TechniquesDNAGoldSARS-CoV-2COVID-19Equipment DesignHumansMetal NanoparticlesNanotechnologyRoboticsSalivaVirionAptamers, NucleotideDNAGold

Identifiers

PMID39602515
PMCPMC11750070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.